Answers are grounded in this paper and cite their sources.
Review outlines continuous kidney replacement therapy protocols for patients receiving mechanical circulatory support, highlighting strategies to manage complex access and fluid balance.
Mechanical circulatory support (MCS) devices, including intra-aortic balloon pumps, micro-axial flow pumps, venoarterial extracorporeal membrane oxygenation, and ventricular assist devices, have become increasingly common in managing advanced heart failure and cardiogenic shock. Acute kidney injury (AKI) occurs in up to 85% of MCS patients, with 30-45% treated with kidney replacement therapy (KRT). Continuous KRT (CKRT) is generally preferred in this population due to superior hemodynamic tolerability and precise volume control. However, providing CKRT to MCS patients presents unique challenges, including securing a functional vascular access, circuit integration considerations, dual-device blood flow optimization, and anticoagulation management. This review provides practical guidance for nephrologists caring for patients treated with both MCS and CKRT. We describe current MCS technologies and discuss evidence-based approaches to CKRT prescription including modality selection, timing of initiation, vascular access techniques, and anticoagulation strategies. We also address volume management, safety monitoring, and troubleshooting common complications. Despite high short-term mortality, many survivors achieve renal recovery by hospital discharge, emphasizing the importance of optimized CKRT delivery in this complex population.
No takes yet. Share an insight, caveat, or question.
Teixeira et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: